| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |